Loneliness research shifts from metaphor to biomarkers

Matthew Lieberman links loneliness to inflammation, public health campaigns chase a hard-to-measure cause, evidence still hinges on confounding and measurement choices

Matthew Lieberman has spent three decades arguing that social pain is not just a metaphor. In an interview with El País, the UCLA psychologist says the pandemic accelerated a long-running rise in isolation and left many people with a kind of chronic social deprivation that shows up in biology as well as mood. He points to research linking loneliness with immune activation and inflammation, and to downstream associations with cardiovascular disease, cancer and higher mortality.

The claim that “loneliness kills” has become a policy slogan in several Western countries, but the scientific picture is messier than the slogan. Most of the headline evidence comes from observational studies: people who report being lonely tend to have worse health outcomes later. That relationship is robust across cohorts and countries, but it is also vulnerable to a basic alternative explanation—ill health often precedes isolation. Chronic conditions reduce mobility, shrink social circles and make work and family life harder to maintain. If sickness drives loneliness, then loneliness looks like a cause when it is partly a symptom.

Researchers try to correct for this by controlling for baseline health, income, depression, smoking and other factors, but “adjusting” only works for what is measured well. Loneliness itself is slippery: some studies use living alone, others use frequency of social contact, others use self-reported loneliness, and these do not always move together. A person with a busy social calendar can still report loneliness; a person living alone can report high wellbeing. When definitions vary, effect sizes vary too.

Lieberman’s mechanistic story focuses on inflammation: chronic social threat or lack of support keeps stress responses activated, nudging the immune system toward a higher-alert state. That pathway is plausible and supported by work linking loneliness to inflammatory markers and to altered stress physiology, but it still leaves open the direction of causality. Inflammation also rises with poor sleep, obesity, infection, financial stress and depression—conditions that correlate with loneliness and can be difficult to disentangle in real-world data.

Then comes the intervention problem. If loneliness is a causal risk factor, the most convincing evidence would come from interventions that reduce loneliness and then measurably improve health markers or hard outcomes. But loneliness is not a pill deficiency. Many interventions are small, local and hard to scale; others are easy to scale but mostly symbolic. Video calls and social apps can help people maintain existing relationships, Lieberman says, yet they are weak at creating new close ties—precisely what people need after moving for work or after a relationship breaks.

Governments increasingly talk about “loneliness strategies”, but the levers that shape social connection are often outside health ministries: housing markets that make it expensive to live near family, labour markets that reward geographic mobility, and urban design that turns everyday life into commuting between private spaces. Those forces are not addressed by awareness campaigns, and they do not yield quick metrics for a ministerial press conference.

Lieberman’s interview is a reminder that the science of loneliness is advancing fastest where it can measure biology, while the hardest part—changing the conditions that make stable relationships easier to build—sits in institutions that prefer programs to reform.

In the interview, Lieberman describes 18 months of “bubbling” during Covid as a natural experiment in social deprivation. The evidence that followed still depends on how researchers define loneliness and what they can rule out as the true cause of declining health.